Half of the top 20 Big Pharma are now part of Monocl's customer portfolio!

We have grown rapidly over the past year. The key reason for our fast market uptake is related to the new approach we have taken to information in life science. Gone are the days when a siloed “source by source” analysis approach was sufficient to address challenging requirements and core customer needs – things are simply moving too fast today.

Read more

Top Investigators, established opinion leaders and rising stars within MS

This week, we look into the world of Multiple sclerosis and zero in on top Investigators as well as funding landscape and trends.

Read more

Opinion leaders, up-and-coming researchers and trends within GC-MS

A deep dive into the GC-MS space, where North America and Europe account for nearly two-thirds of the worldwide GC–MS demand. Key stakeholders and rising stars outlined in all geographies, including the two fastest growing regions China and Japan.

Read more

Have an eye out for these medical experts within Ophthalmology

A rapidly ageing population is driving an increase in age-related diseases of the eye. This week, we've focused on the established and up-and-coming experts that are moving the needle in this space.

Read more

The leaders, talents and trends to have on your radar within Bacterial Infections

The established opinion leaders and talents who are on a trajectory towards an influential postition, all mapped and outlined in this weeks issue.

Read more

Who should you be working with in Hepatology?

In this week's 'through the lens' we zero in on liver diseases and outline the experts, institutions and companies that are pushing the envelope in this space.

Read more